What Is Considered Low Free Testosterone?

Unlock the true definition of low free testosterone. We explain the clinical numbers, deficiency symptoms, and common contributing factors.

Free testosterone below roughly 65 pg/mL (225 pmol/L) is widely used as the lower boundary of normal for adult men, though this number shifts depending on age, the laboratory running the test, and the method used to measure it. A large normative study of healthy, non-obese men using a gold-standard measurement technique established a reference range of 66–309 pg/mL across all adult ages, with younger men (19–39) running higher at 120–368 pg/mL. That lower-end figure of about 65 pg/mL also appears in international clinical guidelines as a threshold below which testosterone replacement may be considered when symptoms are present. But that single number hides real complexity in how free testosterone is defined, measured, and interpreted.

Why Free Testosterone Gets Its Own Number

Most testosterone in your blood is bound to proteins, mainly sex hormone-binding globulin (SHBG) and, to a lesser extent, albumin. Only about 1–3% circulates unbound, and this “free” fraction is what enters cells and drives the biological effects you associate with testosterone: libido, muscle maintenance, energy, bone density. The idea behind measuring free testosterone is that total testosterone can look perfectly normal while the amount actually available to your tissues is low, or vice versa.

This matters most when SHBG levels are unusually high or low. If SHBG is elevated, it soaks up more testosterone, leaving less in the free fraction. Your total testosterone blood test might come back in the normal range while your free testosterone is genuinely low. That mismatch is common in specific situations: aging, liver disease, hyperthyroidism, certain medications, and HIV infection. In one study of HIV-positive men, only about 11% would have been diagnosed with low testosterone using total testosterone alone, because elevated SHBG was masking the deficiency. Free testosterone testing caught what total testosterone missed. The reverse also happens: conditions like obesity, type 2 diabetes, and hypothyroidism tend to push SHBG down, which can make total testosterone look low even when free testosterone is adequate.

The Numbers and What They Mean

If you’ve had blood work done and are staring at a free testosterone result, the first thing to check is the unit. Laboratories report free testosterone in pg/mL, pmol/L, or ng/dL, and the numbers look wildly different depending on the unit. A result of 65 pg/mL is the same as 225 pmol/L or 6.5 ng/dL. Many online reference ranges fail to specify the unit clearly, which causes needless confusion.

For adult men across all ages, the normative range established using equilibrium dialysis (the most reliable method) is 66–309 pg/mL. For younger men in their twenties and thirties, the range narrows and shifts upward to 120–368 pg/mL. A separate study of Chinese men in their twenties found a lower cutoff for calculated free testosterone of about 0.22 nmol/L (roughly 63 pg/mL), which aligns closely with the Western data.

International clinical guidelines from the ISSAM (International Society for the Study of the Aging Male) note that free testosterone as low as 65 pg/mL (225 pmol/L) has been recommended as the lower limit of normal. When that number appears alongside symptoms of testosterone deficiency, it supports a case for treatment. But that threshold is not a hard line. A man at 70 pg/mL with fatigue, low libido, and depressed mood might reasonably be evaluated for treatment, while a man at 60 pg/mL who feels fine would not necessarily need intervention. The number provides context, not a verdict.

How Free Testosterone Is Measured and Why It Matters

This is where things get surprisingly messy. The gold-standard method for measuring free testosterone is called equilibrium dialysis. It physically separates unbound testosterone from the bound fraction in a blood sample and measures it directly. The problem is that equilibrium dialysis is expensive, technically demanding, and unavailable at most routine labs. So the vast majority of free testosterone results you see on a lab report come from one of two shortcuts: a direct immunoassay (sometimes called an analog assay), or a calculated estimate derived from your total testosterone and SHBG levels.

Neither shortcut is perfect. Direct immunoassays can produce numbers roughly one-seventh of what equilibrium dialysis would give for the same sample, making it impossible to compare results between methods without knowing which one was used. Calculated free testosterone formulas, such as the widely used Vermeulen equation, tend to correlate well with equilibrium dialysis overall, but they systematically over- or underestimate in certain patients. One study found that regardless of which formula was used, at least a quarter of samples showed unacceptable deviation from the dialysis reference. The accuracy of these formulas depends on the patient’s SHBG level and sex, and high SHBG concentrations in particular tend to throw the calculations off.

What this means practically: if your lab report says your free testosterone is low but your result came from an analog assay, it is worth asking your doctor whether the test method could be skewing the number. If your result was calculated using a formula and you have unusually high or low SHBG, the calculated value may not be reliable. A clinical endocrinologist evaluating borderline cases will often order equilibrium dialysis or at minimum a calculated estimate using a validated formula alongside SHBG and albumin measurements.

How Age Changes the Picture

Free testosterone declines with age more steeply than total testosterone does. In men over 70, total testosterone may actually hold steady or even inch upward slightly, while free testosterone continues to fall. The reason is that SHBG tends to rise as men get older, binding more of the available testosterone and shrinking the free fraction. This divergence between total and free testosterone is one of the main reasons clinicians measure free testosterone in the first place, especially in older men.

A 70-year-old with a total testosterone of 400 ng/dL might look fine on paper but have a free testosterone well below the range seen in younger men. Whether that lower free testosterone is “pathological” or simply a normal part of aging remains genuinely debated. The European Male Ageing Study identified several patterns: some older men have low testosterone with low signaling from the pituitary (secondary hypogonadism), some have low testosterone with high pituitary signaling (primary hypogonadism), and others have technically normal total testosterone but elevated pituitary hormones suggesting the body is working harder to maintain those levels (compensated hypogonadism). Free testosterone helps sort out which category someone falls into.

What Symptoms Actually Correlate with Low Free Testosterone

Not every symptom popularly blamed on “low T” has strong evidence linking it to testosterone levels. A large European study of over 3,000 middle-aged and older men found that only three symptoms had a clear, consistent relationship with declining testosterone: poor morning erections, reduced sexual desire, and erectile dysfunction. These sexual symptoms became increasingly likely as free testosterone dropped below roughly 160–280 pmol/L (about 46–81 pg/mL). Reduced ability to perform vigorous physical activity also correlated with lower testosterone in that study, though less consistently than the sexual symptoms.

Fatigue, depressed mood, and difficulty concentrating are commonly listed as symptoms of low testosterone, and testosterone deficiency can contribute to all of them. But those symptoms also have dozens of other causes, from sleep apnea to depression to thyroid dysfunction. A low free testosterone level alongside persistent sexual symptoms is a much stronger signal than low free testosterone alongside vague tiredness alone. Clinicians diagnosing testosterone deficiency typically require both a low lab value and the presence of characteristic symptoms. A number by itself does not establish a clinical problem.

When to Get Tested and How Timing Affects Results

Testosterone, including the free fraction, follows a daily rhythm. Levels peak in the early morning, around 7:00–7:30 AM, and fall throughout the day. In young men, free testosterone can swing by more than a third from peak to trough over 24 hours. Middle-aged men show a similar pattern, though some studies suggest the rhythm flattens somewhat with age.

Because of this daily swing, most guidelines recommend drawing blood in the morning, ideally before 10 AM, and confirming a low result with a second test on a different day. An afternoon blood draw can produce a result 30–40% lower than a morning draw from the same person, enough to push a borderline result below the cutoff and create a misleading impression of deficiency. If you had your blood drawn at 3 PM and your free testosterone came back borderline low, a repeat morning test is worth requesting before drawing any conclusions.

Medications and Lifestyle Factors That Lower Free Testosterone

Several commonly prescribed medications suppress testosterone. Long-term glucocorticoids (like prednisone) are among the most well-documented culprits. In one study, testosterone levels dropped to roughly half of normal in men on chronic glucocorticoid therapy, with higher doses producing bigger drops. Certain anti-seizure medications also lower free testosterone while simultaneously raising SHBG, creating a double hit: less testosterone produced and more of it bound up. Opioids, some antidepressants, and drugs used to treat prostate cancer are other known suppressors. If you are on any of these and have symptoms consistent with low testosterone, mentioning the medication to your doctor is important context.

Sleep restriction is another factor with surprisingly clear data behind it. A small controlled study in healthy young men found that limiting sleep to five hours a night for just one week reduced daytime testosterone levels by 10–15%. Chronic sleep deprivation likely compounds the effect. Excess body fat also drives testosterone down through multiple routes: fat tissue converts testosterone to estrogen, obesity raises insulin levels which suppresses testicular function, and excess weight tends to lower SHBG. These factors create a feedback loop where low testosterone promotes fat gain and fat gain further lowers testosterone.

The Metabolic Connection

Low testosterone and metabolic problems are deeply intertwined. Men with metabolic syndrome and type 2 diabetes have a high prevalence of low testosterone, and the relationship runs in both directions. Longitudinal data show that men with the lowest testosterone at baseline developed higher insulin resistance years later, but high insulin resistance at baseline did not reliably predict future low testosterone. This suggests that low testosterone may be more of a cause than a consequence of metabolic deterioration, at least in part.

Men with metabolic syndrome also tend to have lower SHBG levels, which means their total testosterone may look deceptively low while free testosterone is less affected. However, in some of these men, free testosterone is genuinely low as well. A study of men with metabolic syndrome found that those with higher body mass, larger waist circumferences, and greater insulin resistance had both lower SHBG and lower free testosterone compared to metabolically healthier controls. Sorting out whether a man’s low total testosterone reflects genuinely low androgen exposure or is just an artifact of shifted SHBG is exactly where free testosterone measurement earns its keep.

Genetic Variation in SHBG and What It Means for Your Numbers

Your genes influence how tightly SHBG grips testosterone, and this introduces a subtle problem for standard testing. A common genetic variant called rs6258 in the SHBG gene changes the shape of the SHBG protein just enough to weaken its grip on testosterone. People carrying this variant have SHBG that binds testosterone less tightly, which means more testosterone is functionally “free” even if standard lab calculations do not account for it.

Standard calculated free testosterone formulas assume SHBG binds testosterone with the same strength in everyone. When that assumption is wrong because of genetic variation, the formula can spit out a misleading number. A man with an SHBG variant that weakens binding might have more functional free testosterone than his lab report suggests, while a man with a tighter-binding variant might have less. Research has flagged this as a potential source of misdiagnosis: for certain genetic variants, free hormone calculations that assume constant binding affinity could lead to incorrect conclusions. Genetic testing for SHBG variants is not standard practice yet, but it is a known limitation of current diagnostic approaches.

Free Testosterone in Women

Although the conversation around low testosterone focuses overwhelmingly on men, women produce testosterone too, and their free testosterone levels matter for libido, energy, and sense of well-being. The challenge is that women’s testosterone levels are a fraction of men’s, and the assays commonly used in clinical labs were designed for the male range. At the low concentrations seen in women, these tests become unreliable, making it difficult to define what “low” even means in a female context. There is currently no agreed-upon minimum free testosterone level that reliably correlates with symptoms of androgen insufficiency in women. Women experiencing symptoms suggestive of low testosterone, such as persistent low libido, fatigue, and reduced sense of well-being, are often diagnosed clinically rather than purely by lab values.

Testosterone, Cognition, and the Brain

Population studies have found that men with lower testosterone tend to have higher rates of cognitive decline and dementia, including Alzheimer’s disease. This has prompted interest in whether testosterone replacement might protect the aging brain. So far, the evidence is underwhelming. A randomized trial of 788 men aged 65 and older with low baseline testosterone found that one year of testosterone treatment improved sexual function but produced no measurable improvement in cognitive function. The association between low testosterone and cognitive decline may reflect shared underlying causes, like vascular disease or chronic inflammation, rather than a direct causal pathway. For now, low free testosterone is not a reliable marker for cognitive risk, and treating it does not appear to be a shortcut to brain health.